Cold and Heat Investigation to Lower Levels of Depression (CHILL'D Study)
This study, called the CHILL'D Study, is looking into how heat therapy, sometimes with a cold plunge, might help people with depression. Researchers want to see if a single session of Whole Body Hyperthermia (heat therapy) followed by a cold water plunge works better to improve mood than just the heat therapy alone. You might be able to join if you are 18 to 65 years old and are currently experiencing symptoms of depression, or if you do not have depression but want to participate as a healthy control. The study will measure changes in your depression symptoms using a scale called the Montgomery-Åsberg Depression Rating Scale (MADRS) at the start, and then one and two weeks after treatment. The current recruitment status is unclear.
- Study design
- This is an interventional study planning to enroll 162 participants, including those with depression and healthy controls. Participants will be randomly assigned to receive either heat therapy alone or heat therapy followed by a cold plunge.
- What's involved
- Participants will attend a baseline assessment, a single treatment session lasting up to 140 minutes (with an additional 10 minutes for cold plunge if assigned), and follow-up assessments one and two weeks after treatment.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for two weeks after their treatment session to assess changes in depression symptoms.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Cold and Heat Investigation to Lower Levels of Depression
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Barry Sandler, DO · PRINCIPAL_INVESTIGATOR · Vail Health Behavioral Health
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Montgomery-Åsberg Depression Rating Scale (MADRS)Baseline/Treatment (Visit 1), 1 Week Post-Treatment (Visit 2), 2 Weeks Post-Treatment (Visit 3)
The MADRS is a validated 10-item questionnaire to assess depression severity and is commonly used to assess efficacy of an intervention in clinical trials. Each item of the MADRS is measured on a scale of 0 to 6 (for a total score of 0 to 60) with higher scores indicating more severe depression. The MADRS includes questions on the following symptoms: 1. Reported sadness; 2. Apparent sadness; 3. Inner tension; 4. Reduced sleep; 5. Reduced appetite; 6. Concentration difficulties; 7. Lassitude; 8. Inability to feel; 9. Pessimistic thoughts; 10. Suicidal thoughts. Items are scored via a clinical interview that progresses from more broadly phrased questions about symptoms to more detailed queries that allow a precise rating of severity.